Heart Patient Risk From iPad2 Found by 14-Year-Old

Heart Patient Risk From iPad2 Found by 14-Year-Old

Gianna Chien is somewhat different from all the other researchers reporting on their work today to more than 8,000 doctors at the Heart Rhythm Society meeting.

Chien is 14, and her study — which found that Apple Inc. (AAPL)’s iPad2 can, in some cases, interfere with life-saving heart devices because of the magnets inside — is based on a science-fair project that didn’t even win her first place.

The research offers a valuable warning for people with implanted defibrillators, which deliver an electric shock to restart a stopped heart, said John Day, head of heart-rhythm services at Intermountain Medical Center in Murray, Utah, and chairman of the panel that reviews scientific papers to be presented at the Denver meeting.

If a person falls asleep with the iPad2 on the chest, the magnets in the cover can “accidentally turn off” the heart device, said Chien, a high school freshman in Stockton, California, whose father is a doctor. “I definitely think people should be aware. That’s why I’m presenting the study.”

Defibrillators, as a safety precaution, are designed to be turned off by magnets. The iPad2 uses 30 magnets to hold the iPad2’s cover in place, Chien said. While the iPad2 magnets aren’t powerful enough to cause problems when a person is holding the tablet out in front of the chest, it can be risky to rest it against the body, she found.Apple Guide

Trudy Muller, an Apple spokeswoman, declined to comment on the study in an e-mail, referring questions about the iPad2’s safety to its on-line product safety guide. The guide cautions users about radio frequency interference, suggests that patients with pacemakers keep the iPad at least six inches away and says they should be turned off in health-care facilities when instructed by staff or posted signs.

The study involving 26 volunteers with defibrillators found “magnet mode” was triggered in 30 percent of patients who put the tablet on their chest. The iPad2 didn’t interfere with four pacemakers or a loop-recorder, which were also tested. Walter Chien, a cardiac electrophysiologist, helped his daughter coordinate the patient testing.

Most defibrillators will turn back on once the magnet is no longer affecting the device. Some, however, remain off until the magnet is reapplied or the device is turned back on manually, the younger Chien said. Patients should be told about the risk and doctors should check the devices to see if they have been inadvertently turned off by magnets, she said.

Birthday Gift

Chien said she received an iPad2 for her birthday in August 2011. She was struck at the time by the number of older customers taking a class on how to use the device at the company store and, given her father’s specialty, wondered if there could be a connection between the iPads and their heart devices.

“I don’t think anyone really knows about the risks,” Chien said.

The results are important because they can help raise awareness, said Day, the heart meeting official, in a telephone interview. “Defibrillator patients can still buy Apple products,” he said. “Just don’t put them on your chest.”

A regular at Johns Hopkins University’s Center for Talented Youth, Chien doesn’t see herself becoming a doctor. At the camp, she regularly participates in the writing program and she said that one of her favorite parts of the iPad2 project was summing the results for publication in a medical journal. Eventually, she wants to write a novel, she said.

Chien first presented her results in the San Joaquin County Science Fair’s high school category in March, but the project was beat out for the top spot by work on electromagnetics and on the effect of punctuation mark placement in keyboards on carpal tunnel syndrome.

Chien, who rows in her free time, says she may revisit the issue for next year’s science fair, looking at the risks with other electronic products.

To contact the reporter on this story: Michelle Fay Cortez in Minneapolis at mcortez@bloomberg.net

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment